INTRODUCTION
Women die as a result of complications during and following pregnancy and childbirth. Most of these complications develop during pregnancy. The major complications that account for nearly 75% of all maternal deaths are severe bleeding (mostly bleeding after childbirth), infections (usually after childbirth), high blood pressure during pregnancy, complications from delivery unsafe abortion. 1 In India, roughly one maternal death occurs every five minutes. 2 Hypertensive disorders complicating pregnancy are common and form one of the deadly triad ,along with haemorrhage and infection , that results in much of the maternal morbidity and mortality related to pregnancy. How pregnancy incites or aggravates hypertension remains unsolved despite decades of intensive research , and hypertensive disorders remain among the most significant unsolved problems in obstetrics. 3 Preeclampsia is a multisystem disorder of unknown etiology characterised by development of hypertension to the extent of 140/90 mm Hg or more with protinuria after the 20th week in previously normotensive and non-proteinuric patients. 4 Pre-eclampsia is a complex pathophysiological state where regulatory systems of inflammation and endothelial function are stimulated beyond the physiological limits of normal pregnancy.
etc. 5 The antigens of ABO blood-group areoligosaccharides that are attached to the cell-surface glycoconjugates and are expressed by epithelia, endothelia and erythrocytes (RBCs) in primates. Susceptibility to diseases such as infections, cancer, cardiovascular diseases and hematologic disorders are found to be been associated with ABO blood groups. It is a key determinant of coagulation factor VIII and von Willebrand factor plasma concentrations. 8 ABO antigens may alter the presentation of cell-surface glycans and modulate their interactions with pathogens or may provide receptors for pathogen attachment, hence ABO antigen is associated with various diseases. ABO antigens may play a major role in the interaction of the immune and coagulation systems by influencing geneenvironment interactions. As the current view on preeclampsia suggests that it has an exaggerated maternal systemic immune response component and characteristic changes in coagulation systems, differences in ABO blood groups may increase the risk of disease according to the inherited antigens.
METHODS
This cross sectional study was conducted at Navodaya medical college. Institutional ethical clearance was taken. An informed consent was taken from every patient after full explanation of procedure. The subjects for the study were selected from the out-patient and in -patient department of obstetrics and gynaecology and also from the labour room. 100 pregnant women who were fulfilling the criteria for preeclampsia were considered as cases and 100 women with normal pregnancy without any complications were selected as controls. Only Rh positive primi cases were included in the study. Subjects having any other medical and surgical complication and women having history of any drug use, multi-fetal pregnancy, Rh negative blood group subject smoking, erythroblastosis fetalis, were excluded from the study. Relevant past and personal history from the subjects are taken. General physical examination, vital signs were recorded. A drop of blood was taken from their finger tip using lancet, under aseptic precaution. 1 drop of blood was mixed with 1 ml of normal saline in a test tube. This provided the red cell suspension. Blood group was determined by haemagglutination technique. A drop of monoclonal Anti A, Anti B, Anti D was added separately on a clean glass slide and to each of this a drop of red cell suspension was added. With separate applicator, the serum was well mixed back and forth and observed for agglutination and it was confirmed under low power objective. Results of agglutination were recorded immediately for ABO blood group and after 2 minutes for Rh. The protenuria was measured by urine dipsticks.
Statistical Analysis
The data were analyzed by using Microsoft Excel and Epinfo. The relationship of blood group with preeclampsia was estimated by calculating odds ratio from logistic regression models using blood group O and controls respectively as reference group after adjustment for various covariates. A p-value of <0.05 was considered as statistically significant.
RESULTS
The study population consist of 100 cases and 100 controls. Using blood group O as the reference group, the association between blood group and preeclampsia was estimated using odds ratios and 95% confidence intervals from logistic regression models. The results as shown in table-2 indicated that AB has the highest, and O has lowest risk for PIH among the ABO blood groups. 
DISCUSSION
The results of our study indicate that women with blood group AB have the highest risk for preeclampsia compared to other blood group. Preeclampsia, a syndrome unique to human pregnancy and one of the leading causes of maternal and foetal morbidity and mortality, is also associated with maternal blood group.
Patients with blood group AB have an increased risk of severe, early-onset, or intrauterine growth restriction (IUGR) associated forms of preeclampsia. 8 The results of our study are consistent with findings of Lee BK et al 9 Bharali et al 10 Spinillo et al 11 C Phaloprakram et al. 12 One suggested mechanism of how blood group influences the risk of gestational hypertensive disorders is through the maternal immune response. Placental Protein 13 (PP13) is considered to be an early marker for preeclampsia. PP13 is primarily produced by the placenta in anthropoid primates It is a galectin (galectin-13) that binds betagalactosides, such as N-acetyl-galactosamine, galactose, fucose, located at terminal positions on ABO blood-group antigens, with strongest affinity to blood group AB. 8 In women from AB group, the close proximity of A and B antigens could explain the stronger binding of PP13 to blood group AB erythrocytes, leading to its sequestration. In consequence the PP13 plasma levels are low in pregnant on the first trimester of gestation, which could predispose pregnancy complications, including preeclampsia. 13 Compared with O group, A, B, and AB groups are associated with an increased risk of thrombotic events, although this relationship is debated. ABO blood groups may differ in the occurrence of known vascular risk factors for preeclampsia, such as endothelial dysfunction 14 , insulin resistance, 15 and hypercholesterolemia. 16 ABO blood group is a key determinant of coagulation factor VIII and von Willebrand factor plasma concentrations. Low plasma concentrations of these glycoproteins in blood-group O individuals may lead to excess bleeding, while elevated plasma concentrations of these factors in non-O bloodgroup individuals have been implicated in increasing the risk of thromboembolic and ischemic heart diseases. 8 Recent genome-wide association studies indicate that genetic variants at the ABO locus are associated with soluble E-selectin, 17 ,18 P-selectin, and ICAM-1, 19 vascular inflammatory agents that are associated with hypertension and type-2 diabetes. 20 However, of a diverse panel of inflammatorybiomarkers, including Eselectin, P-selectin, and ICAM-1, a recentstudy found that only E-selectin levels were higher in preeclampsiacases versus controls.
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CONCLUSIONS
The results of this study suggest relationship between ABO blood group systems and PIH preeclampsia with AB blood group women having highest risk.. Considering the role of ABO blood groups on the hemostatic process and thrombus formation, special attention should be given to pregnant patients carrying the AB blood group in order to prevent the preeclampsia and improve prognosis.
